US 10011588
1,2-substituted cyclopentanes as orexin receptor antagonists
granted A61KA61K31/44A61K31/4439
Quick answer
US patent 10011588 (1,2-substituted cyclopentanes as orexin receptor antagonists) held by Takeda Pharmaceutical Company Limited expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/44, A61K31/4439, A61K31/4965, A61K31/497